InvestorsHub Logo
Followers 189
Posts 9484
Boards Moderated 0
Alias Born 07/22/2015

Re: Al4door post# 178847

Wednesday, 06/20/2018 2:24:02 PM

Wednesday, June 20, 2018 2:24:02 PM

Post# of 689403
"According to the news release, the vaccine, called SurVaxM, stimulates the immune system to kill tumor cells that contain survivin, a protein that helps cancer cells resist conventional treatments. It was developed at Roswell Park Cancer Institute in New York and is being developed by a company called MimiVax."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News